- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06137625
Rhythm Effect on Dance Learning in Typical Development Children and Children With Motor Disorders. (DANS-APP)
December 23, 2025 updated by: University Hospital, Toulouse
Rhythm Effect on Dance Learning and Associated Functions in Typical Development Children and Children With Motor Disorders.
Cerebral Palsy (CP) or Developmental Coordination Disorder (DCD) leads to motor troubles impacting the everyday life, social participation and academic difficulty .
According to some authors, CP and DCD pertain to a same continuum of motor disorders (MD) (Pearsall-Jones et al., 2010).Those children show an alteration in Perceptivo-Motor Procedural Learning (PMPL), corresponding to the acquisition of everyday life skill (for CP: Gagliardi et al., 2011; Gofer-Levi et al., 2013; for DCD: Gheysen et al., 2011; Blais et al., 2018).
Also, recommended rehabilitation for this population are based on procedural learnings (for CP: Novak et al., 2013; for DCD: Blank et al., 2019; Inserm, 2019).
It's true for dancing which present high evidence to enhance motor, cognitive, psychoaffective and social functions of this children (Cherriere, Martel, et al., 2020; Cherriere, Robert, et al., 2020).
Dance is a physical activity that involve procedural learning to memorise movement sequences (choreography).
Rhythm can be define as a stimuli repetition at a regular interval (Grahn & Brett, 2007; Patel, 2003).
Recently studies tend to shown that rhythm is essential to enhance motor control and procedural learning (Ghai et al., 2022; Lagarrigue et al., 2021).
To validate this hypothesis, the investigators will evaluate typical development children and children with CP MD learning of a dance choreography with and without rhythm.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
68
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: David GASQ, MD
- Phone Number: +33 0561322801
- Email: david.gasq@inserm.fr
Study Contact Backup
- Name: Jessica TALLET, PhD
- Email: jessica.tallet@inserm.fr
Study Locations
-
-
-
Toulouse, France
- Recruiting
- Toulouse Hospital
-
Contact:
- David Gasq, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
For all the participants:
- Aged from 8 to 16 include.
- Free, informed, written, and signed consent of the holders of parental authority
- Free and informed consent of the minor
- Affiliation with or benefiting from a social security scheme.
- Ability to understand the instructions (investigator's assessment)
For the participant with Motor disorders (MD):
For children with CP:
- CP diagnosis
- Gross Motor Function Classification System level between I to IV.
- Manual Ability Classification System level between I to IV.
For children with DCD:
- A diagnosis of DCD
For the participant with typical development:
- No CP diagnosis
- No neurological trouble nor functional disfunction including developmental coordination disorder.
Exclusion Criteria:
- -Autism spectrum disorder diagnosed according to the DSM-5 (APA, 2015)
- Hearing deficiency diagnosed according to the DSM-5 (APA, 2015) or uncorrected hearing deficiency that doesn't allows the participant to hear a music with a sound level between 45 and 70 decibels.
- Visual deficiency diagnosed according to the DSM-5 (APA, 2015)
- Intellectual developmental disorder diagnosed according to the DSM-5 (APA, 2015)
- Behavioural disorders diagnosed according to the DSM-5 (APA, 2015)
- Diagnosed epilepsia
- Pregnancy (check in young pubescent and sexually active women) or breastfeeding.
- Children already include in ongoing interventional study.
- Children with both parent who benefit of legal protection (guardianship, curatorship, safeguard of justice).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Typical developing
Typical developing children
|
All children learn one dance choreographie with regular rhythm music.The pre-recorded choreography is displayed on a large screen in front of the child.
The child practices the choreography by imitating the models in order to learn the sequence movements.
All children learn one dance choreographie without regular rhythm music.The pre-recorded choreography is displayed on a large screen in front of the child.
The child practices the choreography by imitating the models in order to learn the sequence movements.
|
|
Experimental: Motor disorders
Children with motor disporders
|
All children learn one dance choreographie with regular rhythm music.The pre-recorded choreography is displayed on a large screen in front of the child.
The child practices the choreography by imitating the models in order to learn the sequence movements.
All children learn one dance choreographie without regular rhythm music.The pre-recorded choreography is displayed on a large screen in front of the child.
The child practices the choreography by imitating the models in order to learn the sequence movements.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retention score of the choreography
Time Frame: Day 0
|
Number of movements in the choreography performed correctly and in order after practice is analysed by video using a standardised observation grid scored independently and blind to the condition by two trained judges.
|
Day 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the effect of regular rhythm on Perceptivo-Motor Procedural Learning (PMPL)
Time Frame: Day 0
|
The PMPL is measured by an informatised and standardised test (EVAL_App_Kids test)
|
Day 0
|
|
the effect of regular rhythm on sensorimotor function
Time Frame: Day 0
|
the effect is measured by rhythm perception and production task
|
Day 0
|
|
the effect of regular rhythm on cognitive function
Time Frame: Day 0
|
the effect is measured by informatised test on attention and executive function
|
Day 0
|
|
the effect of regular rhythm on psychoaffective function
Time Frame: Day 0
|
the effect is measured by Intrinsic Motivation Inventory questionnaire (IMI)
|
Day 0
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 2, 2024
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2027
Study Registration Dates
First Submitted
November 7, 2023
First Submitted That Met QC Criteria
November 15, 2023
First Posted (Actual)
November 18, 2023
Study Record Updates
Last Update Posted (Actual)
December 31, 2025
Last Update Submitted That Met QC Criteria
December 23, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RC31/22/0039
- ANR-21-CE28-0031 (Other Grant/Funding Number: Agence Nationale de la Recherche (ANR))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Palsy (CP)
-
Ibadat International University, IslamabadRecruitingCerebral Palsy (CP) | Athetoid CPPakistan
-
IRCCS Fondazione Stella MarisUniversity of Siena, ItalyRecruitingCerebral Palsy (CP) | Motor Imagery | CP (Cerebral Palsy) | Action ObservationItaly
-
Cairo UniversityCompletedCerebral Palsy (CP) | Unilateral Cerebral PalsyEgypt
-
University of California, San FranciscoNot yet recruitingCerebral Palsy | Cerebral Palsy (CP) | Infant | Cerebral Palsy InfantileUnited States
-
Holland Bloorview Kids Rehabilitation HospitalCanadian Institutes of Health Research (CIHR)RecruitingCerebral Palsy (CP) | Hemiplegic Cerebral PalsyCanada
-
International Clinic of Rehabilitation, UkraineElita Rehabilitation CenterRecruitingCerebral Palsy (CP)Ukraine
-
University of ThessalyNot yet recruiting
-
Centre Médico-Chirurgical de Réadaptation des Massues...Recruiting
-
Baylor UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingCerebral Palsy (CP)United States
-
Istanbul University - CerrahpasaActive, not recruitingCerebral Palsy (CP)Turkey (Türkiye)
Clinical Trials on With regular rhythm
-
Ziekenhuis Oost-LimburgCompletedAtrial FibrillationBelgium
-
Ziekenhuis Oost-LimburgCompletedAtrial FibrillationBelgium
-
Kuopio University HospitalUniversity of Eastern FinlandCompletedAtrial Fibrillation | Heart Rate Fast | Heart Rate LowFinland
-
The Hong Kong Polytechnic UniversityCompletedEffects of Blue-light Blocking Lens on Visual Functions
-
Rawane El DimachkiSorbonne UniversityCompletedAnalgesic Effects of MusicLebanon
-
GenMont Biotech IncorporationChang Gung Memorial HospitalWithdrawnAlzheimer Disease
-
Kuopio University HospitalUniversity of Eastern FinlandRecruitingAtrial Fibrillation | Heart Rate Fast | Heart Rate Low | Sinus RhythmFinland
-
Laboratório de Pesquisa em Lazer e Atividade FísicaUnknownQuality of Life | Parkinson Disease | Sleep Disorder | Gait Disorders, Neurologic | Mobility Limitation
-
Assaf-Harofeh Medical CenterHadassah Medical Organization; Western University, CanadaNot yet recruitingADHD | Memory Impairment | T1DM | Sleep Disorders, Circadian Rhythm
-
Catholic University of the Sacred HeartFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta; ASST Fatebenefratelli... and other collaboratorsRecruitingDevelopmental DyslexiaItaly